Ikarian Capital, LLC Silence Therapeutics PLC Transaction History
Ikarian Capital, LLC
- $328 Million
- Q2 2025
A detailed history of Ikarian Capital, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Ikarian Capital, LLC holds 873,568 shares of SLN stock, worth $6.26 Million. This represents 1.55% of its overall portfolio holdings.
Number of Shares
873,568Holding current value
$6.26 Million% of portfolio
1.55%Shares
3 transactions
Others Institutions Holding SLN
# of Institutions
57Shares Held
20.6MCall Options Held
22.8KPut Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$21.8 Million3.59% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$20.9 Million0.87% of portfolio
-
Redmile Group, LLC San Francisco, CA2.16MShares$15.5 Million1.53% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$13.3 Million0.9% of portfolio
-
Morgan Stanley New York, NY1.21MShares$8.69 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $257M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...